Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2021/05/033443
CTRI/2021/05/033443
Not yet recruiting
Phase 2

A Comparative Randomized Clinical trial of Ingudi Lepa and Jatiphala Lepa in the management of Vyanga with special reference to Melasma

ational Institute of Ayurveda0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
ational Institute of Ayurveda
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients presenting Vyanga as clinical features according to Susruta Samhita.
  • •2\. Patients of either sex.
  • •3\. Patients of age between 18 \- 60 years.

Exclusion Criteria

  • •1\. Melasma due to tubercular therapy or malignant cases.
  • •2\. Patients having systemic pathogenesis due to allergy.
  • •3\. Patients having diagnosis of major illness like IHD, HTN, MI, TB, COPD, DM etc. would be excluded from trial.
  • •4\. Diagnosed patients of Carcinoma, Burns, Herpes, Eczema, Psoriasis, Measles, Chickenpox, Leucoderma and Leprosy.
  • •5\. Person suffering from any infective or contagious skin disease or under medication with antibiotics, antifungal and steroid.
  • •6\. Patients of uncontrolled hormonal disease.
  • •7\. Any kind of hereditary skin disorder
  • •8\. With present history of pregnancy and chronic constipation.
  • •9\. Patient suffering from Melasma more than five year.
  • •10\. Patients who are reporting allergy history of trail drugs.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 2
To see the effects of Medicated Oil in the management of HairlossHealth Condition 1: L659- Nonscarring hair loss, unspecified
CTRI/2024/07/070764ational Institute of Ayurveda Jaipur
Completed
Not Applicable
The Randomized Controlled Trial Study of the Incidence of Paclitaxel Hypersensitivity Reaction as First Line drug in Gynecologic Cancer Patients between 2 Steroid Premedication Type: Hydrocortisone & dexamethasone VS Dexamethasone aloneGynecologic cancer patients who had not been received paclitaxel therapy.Hypersensitivity reactionPaclitaxelhypersensitivity reactionanaphylaxisPremedicationHydrocortisoneDexamethasone
TCTR20151122001none52
Completed
Not Applicable
Ayurvedic management of Gridhrasi(Sciatica)
CTRI/2022/03/041118J S Ayurveda Mahavidyalaya30
Not yet recruiting
Not Applicable
A Study to Compare the Efficacy And Safety Of Different Adjuncts To Local Anaesthetic For Labor Pai
CTRI/2023/06/053707Shri B M Patil Medical College
Completed
Not Applicable
Herbal Medicaments in EndodonticsHealth Condition 1: K044- Acute apical periodontitis of pulpal originHealth Condition 2: K044- Acute apical periodontitis of pulpal origin
CTRI/2018/10/016135Kishan K V240